Alerts will be sent to your verified email
Verify EmailSANOFI
Sanofi India
|
Caplin Point Lab
|
Natco Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
1.7 % | n/a | 31.2 % |
Unclassified
|
|||
R&D as a % of Total Sales
|
0.0 | 4.6 % | 7.6 % |
Financials
|
|||
5 yr Average ROE
|
52.02 % | 20.61 % | 13.06 % |
5yr average Equity Multiplier
|
4.62 | 1.17 | 1.18 |
5yr Average Asset Turnover Ratio
|
0.47 | 0.72 | 0.46 |
5yr Avg Net Profit Margin
|
24.38 % | 24.8 % | 23.09 % |
Price to Book
|
16.47 | 5.71 | 2.15 |
P/E
|
34.29 | 30.34 | 8.67 |
5yr Avg Cash Conversion Cycle
|
4.83 Days | 79.85 Days | 10.54 Days |
Inventory Days
|
66.8 Days | 64.55 Days | 99.95 Days |
Days Receivable
|
31.98 Days | 100.92 Days | 86.16 Days |
Days Payable
|
63.37 Days | 74.04 Days | 154.15 Days |
5yr Average Interest Coverage Ratio
|
906.11 | 579.71 | 46.61 |
5yr Avg ROCE
|
27.19 % | 25.27 % | 16.05 % |
5yr Avg Operating Profit Margin
|
24.71 % | 30.87 % | 30.17 % |
5 yr average Debt to Equity
|
0.0 | 0.01 | 0.06 |
5yr CAGR Net Profit
|
31.63 % | 16.28 % | 24.68 % |
5yr Average Return on Assets
|
11.5 % | 17.7 % | 11.07 % |
Shareholdings
|
|||
Promoter Holding
|
60.4 % | 70.56 % | 49.56 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 1.67 % | 0.75 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.07 % | 0.55 % | -5.54 % |